🇺🇸 Rosuvastatin and Ezetimibe in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Kidney Injury — 1 report (16.67%)
  2. Asthenia — 1 report (16.67%)
  3. Balance Disorder — 1 report (16.67%)
  4. Erythema — 1 report (16.67%)
  5. Hyperkalaemia — 1 report (16.67%)
  6. Metabolic Acidosis — 1 report (16.67%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Rosuvastatin and Ezetimibe approved in United States?

Rosuvastatin and Ezetimibe does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Rosuvastatin and Ezetimibe in United States?

Hanmi Pharmaceutical Company Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.